- 4.9Impact Factor
- 9.0CiteScore
- 21 daysTime to First Decision
Identification of Predictive Molecular Markers for Cancer Progression, Response to Therapy, and Disease Outcome
This special issue belongs to the section “Molecular Oncology“.
Special Issue Information
Dear Colleagues,
This Special Issue invites original research articles, reviews, and perspectives focused on novel predictive molecular biomarkers critical for advancing cancer diagnosis, prognosis, and therapy response prediction. We seek studies that explore cutting-edge molecular signatures, multi-omics integration, and innovative technologies such as liquid biopsy, spatial omics, and AI-driven biomarker discovery. Emphasis is on biomarkers that enhance understanding of tumor progression mechanisms, therapeutic resistance, immune response prediction, and clinical outcomes across diverse cancer types. Contributions highlighting translational applications and personalized medicine strategies are particularly encouraged. This Issue aims to foster collaboration across disciplines advancing precision oncology through molecular insights. Submitted manuscripts will undergo rigorous peer review according to journal standards. We welcome submissions from early career researchers to established experts to spark impactful discussions and accelerate clinical utility. Join us in shaping the future of cancer biomarker research.
Dr. Shadma Fatima
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- predictive biomarkers
- cancer progression
- therapy response
- molecular signatures
- precision oncology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

